Trials / Not Yet Recruiting
Not Yet RecruitingNCT06727890
Compound Danshen Dripping Pill for Diabetic Microvascular Angina
The Efficacy and Safety of Compound Danshen Dripping Pill in Patients With Diabetic Microvascular Angina
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 162 (estimated)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the efficacy and safety of Compound Danshen Dripping Pill in patients with diabetic microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Compound Danshen Dripping Pill on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Danshen Dripping Pill | Danshen Dripping Pill, 10 pills once, three times a day |
| DRUG | Placebo | Placebo, 10 pills once, three times a day |
Timeline
- Start date
- 2025-01-01
- Primary completion
- 2026-12-31
- Completion
- 2027-06-30
- First posted
- 2024-12-11
- Last updated
- 2024-12-11
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06727890. Inclusion in this directory is not an endorsement.